We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKX
601
DELISTED
Skechers
SKX
| $4.9M | 0.02% |
113,400
-8,400
| -7% | -$331K |
|
|
NSA
602
DELISTED
National Storage Affiliates Trust
NSA
| $4.86M | 0.02% |
144,600
-3,500
| -2% | -$117K |
|
603
XP
XP
$9.96B
| $4.86M | 0.02% |
+126,142
| New | +$4.74M |
|
|
TCO
604
DELISTED
Taubman Centers Inc.
TCO
| $4.85M | 0.02% |
155,975
+142,000
| +1,016% | +$4.87M |
|
|
MDRX
605
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.75M | 0.02% |
484,300
-1,500
| -0.3% | -$15.8K |
|
|
MPT
606
Medical Properties Trust
MPT
$2.11B
| $4.74M | 0.02% |
224,580
-358,500
| -61% | -$7.26M |
|
|
ONC
607
BeOne Medicines Ltd
ONC
$39.2B
| $4.74M | 0.02% |
28,595
+718
| +3% | +$119K |
|
608
Lamb Weston
LW
$6.63B
| $4.71M | 0.02% |
54,800
-85,100
| -61% | -$6.85M |
|
609
Cencora
COR
$61.3B
| $4.71M | 0.02% |
55,343
+1,500
| +3% | +$129K |
|
610
Labcorp
LH
$26.3B
| $4.71M | 0.02% |
32,381
+6,061
| +23% | +$875K |
|
611
Aecom
ACM
$8.22B
| $4.71M | 0.02% |
109,100
+62,500
| +134% | +$2.59M |
|
612
Progress Software
PRGS
$1.76B
| $4.7M | 0.02% |
113,100
+66,836
| +144% | +$2.72M |
|
613
Enbridge
ENB
$106B
| $4.68M | 0.02% |
117,646
+3,441
| +3% | +$129K |
|
614
NovoCure
NVCR
$1.92B
| $4.68M | 0.02% |
55,500
-22,000
| -28% | -$1.78M |
|
615
Aflac
AFL
$59B
| $4.67M | 0.02% |
88,311
+15,679
| +22% | +$832K |
|
|
LSI
616
DELISTED
Life Storage, Inc.
LSI
| $4.67M | 0.02% |
64,679
-6,300
| -9% | -$450K |
|
|
GES
617
DELISTED
Guess Inc
GES
| $4.67M | 0.02% |
208,600
-18,100
| -8% | -$337K |
|
618
Wolverine World Wide
WWW
$1.62B
| $4.66M | 0.02% |
138,200
-8,300
| -6% | -$259K |
|
619
Ventas
VTR
$45.6B
| $4.66M | 0.02% |
80,704
+1,615
| +2% | +$101K |
|
620
Kemper
KMPR
$1.62B
| $4.65M | 0.02% |
60,000
| – | – |
|
621
Veracyte
VCYT
$3.21B
| $4.64M | 0.02% |
166,200
-52,450
| -24% | -$1.36M |
|
622
Acushnet Holdings
GOLF
$4.88B
| $4.63M | 0.02% |
142,300
+51,800
| +57% | +$1.54M |
|
|
OPI
623
DELISTED
Office Properties Income Trust
OPI
| $4.58M | 0.02% |
142,500
+100,500
| +239% | +$3.22M |
|
624
Limoneira
LMNR
$238M
| $4.58M | 0.02% |
238,137
| – | – |
|
625
Trip.com Group
TCOM
$25.5B
| $4.58M | 0.02% |
136,382
+4,754
| +4% | +$153K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.